Medical Device News Magazine

Kleiner Device Labs Completes First 50 Surgical Cases With KG2 Surge Flow-Thru Interbody System

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Kleiner Device Labs today announced that its new KG®2 Surge®flow-thru interbody system was recently used in its 50th surgical case.

Noted founder and CEO Jeff Kleiner, MD, “The new KG2 Surge was developed with the objectives of maximizing bone graft delivery to the prepared intervertebral disc space, and streamlining implant placement, positioning, and integration in the graft matrix.  The first fifty cases demonstrated excellent achievement of those objectives.  We will next be moving to broader commercial availability, expanding our network of distributors and independent representatives.”

“Overall, I think surgeons have lost track of the importance of meticulous disc space preparation and abundant, quality bone graft delivery and packing into the disc space well enough to achieve high fusion rates,” said surgeon Jeffrey Dick, MD, of Twin Cities Orthopedics.  “One of the best things about the KG2 is the ease with which one can deliver abundant bone graft through the tube and how tightly you can pack it compared to conventional techniques.”

Neurosurgeon Catherine Gallo, MD of Two Rivers Surgical Center in Eugene, Oregon, said, “I can tell that the KG2 is a very well-thought-out cage design.  Somebody put some real thought into this.  It is very user-friendly.”

Orthopedic spine surgeon Blake Burkert, MD, of NeuroSpine in Eugene, Oregon, commented, “I will change my approach and do more PLIFs because the KG2 system is so easy to use and the graft volume is impressive.  Love this cage system.”

The KG2 Surge flow-thru interbody system is a single-patient-use bone graft delivery tool coupled with a 3D-printed titanium I-Beam fusion implant. The implant has no lateral walls and serves as a conduit for unimpeded flow of a broad spectrum of bone graft materials through the pre-attached, rectangular insertion tool. The rectangular cannula maximizes the cross-sectional area available for graft material flow and eliminates the challenge of trying to apply bone graft after cage insertion. Since the system comes pre-assembled and sterilized in a single use tray, there is minimal scrub tech training and no implant tray re-processing/sterilization — an ideal system for an ASC or hospital. The KG2 system allows for a single insertion process to take the place of the multi-step, multi-instrument pass practice. The surgical procedure with KG2 Surge spares contusion of delicate nerve tissue and reduces the risk of surgical site infection.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”